A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Clinical trial NCT02584855 · COMPLETED
Trial details
- NCT number
- NCT02584855
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2018-10-30
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.